First, our results showed that DNA‐PK expression was significantly increased in splenic MDSCs of tumor‐bearing mice compared with that in healthy control mice (Figure S9), which was consistent with previous researches that patients with breast cancer showed higher PRKDC (DNA‐PK coding gene) expression than healthy controls. This evidence concerns the gene PRKDC and breast carcinoma.